Neolpharma Recalls Subpotent Alprazolam Tablets Nationwide

Plain-English summary

Neolpharma, Inc. is voluntarily recalling 12,310 bottles of Alprazolam tablets, USP, CIV, 0.25 mg, Rx Only. The affected products are distributed by Greenstone LLC and are available in 500-count and 1,000-count bottles. The recall covers two specific lots: Lot C100429 (Expiration 03/15) and Lot C120293 (Expiration 01/17).

The recall was initiated because the medication was identified as subpotent, meaning it did not contain the full amount of the active ingredient required by the United States Pharmacopeia (USP). The FDA classified this recall as Class II, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

The affected products were distributed nationwide. Consumers and healthcare providers should check their inventory for the specific NDCs and lot numbers listed in the recall notice. Those who have purchased or received these specific bottles should contact their pharmacist or the recalling firm for instructions on how to return the product or obtain a replacement.

The recalled product

Product

ALPRAZOLAM (ALPRAZOLAM)

Brand

ALPRAZOLAM

Manufacturer

Neolpharma, Inc.

Category

Drug — Prescription Medication

Hazard

• subpotent-drug

Affected units

12,310

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Related recalls